Compare Nucor Corporation (NUE) vs TG Therapeutics Inc (TGTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nucor Corporation vs TG Therapeutics Inc — how do they compare? Nucor Corporation trades at $230.8 (market cap $52.55B), while TG Therapeutics Inc trades at $54 (market cap $8.26B). The key difference: Nucor Corporation is far larger — about 6.4× TG Therapeutics Inc's market cap, and Nucor Corporation pays a 0.97% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| NUE | TGTX | |
|---|---|---|
Market Cap | $52.55B | $8.26B |
Sector | Basic Materials | Health |
52-Week High | $266.35 | $59.06 |
52-Week Low | $131.78 | $26.39 |
Enterprise Value | $57.19B | $8.50B |
Dividend Yield | 0.97% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nucor Corporation
Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products and raw materials, the steel mills segment derives maximum revenue.
Read more on NUE →About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →
